ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1

Molecular targeted therapy using poly (ADP-ribose) polymerase inhibitors has improved survival in patients with castration-resistant prostate cancer (CRPC). However, this approach is only effective in patients with specific genetic mutations, and additional drug discovery targeting epigenetic modula...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Sayuri, Takada, Ichiro, Hashimoto, Kenichi, Yokoyama, Atsushi, Nakagawa, Tohru, Makishima, Makoto, Kume, Haruki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390525/
https://www.ncbi.nlm.nih.gov/pubmed/37524814
http://dx.doi.org/10.1038/s41598-023-39626-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390525/
https://www.ncbi.nlm.nih.gov/pubmed/37524814
http://dx.doi.org/10.1038/s41598-023-39626-0

Ejemplares similares